Matt Henriksen

Welcome to another episode of the Vanguards of Healthcare series.

My name is Matt Henriksen, the Medical Technology Analyst at Bloomberg Intelligence, which is the in-house equity research platform of Bloomberg LP.

We are pleased to have with us today Sean Saint, CEO of Beta Bionics, a medical device company that is a key leader in the expansion of automated insulin delivery systems, or AIDs for short, the next generation of insulin pumps to help diabetic patients keep track of their glucose levels.

You can dive deeper into the financials by typing in BBNX Equity Go on your Bloomberg terminal.

Sean, thank you for joining us today.

Thanks for having us, Matt.

And Sean, you know, you started the role of Beta Bionic CEO a few years ago, but what

You've had a long history in the diabetes space, at a personal level as well.

So why don't we start with, for the listeners, a story of your path that got you to the CEO role today?

Yeah, quite a career.

And what caught my attention is you were diagnosed with, I mean, was this type one or type two diabetes you were diagnosed in your adult years?

Yeah, I feel like my wife's on the same boat there.

But it's interesting, though, because it just makes you think that you have this – we'll dive deeper into kind of the market opportunities and the patient pools that can benefit from these AIDs.

But just the fact that it just – when we go into that, knowing that the type 1 –

the patients that can benefit from this, it's not a static number.

It's an ever-evolving number, which is I always find interesting with how the disease progresses with some of these patients.

Yeah, and let's maybe take a step back about how insulin used to be delivered to these patients.

You know, because as you said, it's been a 20-plus year journey for, you know, the technology that's now in the market.

But walk us through, for these patients who need insulin, what were the steps that they had beforehand and then kind of has progressed to now what we're calling, you know, the AIDs?

Yeah, and it's interesting because from your perspective, it sounds like